# Spyre Therapeutics, Inc.: Form 8-K, filed Nov 18, 2024

- Company: [Spyre Therapeutics, Inc.](/companies/syre.md) (CIK 1636282)
- Form: 8-K
- Filed: 2024-11-18
- Accepted by EDGAR: Nov 18, 2024, 21:01 ET
- Period: 2024-11-18
- Accession: 0001636282-24-000105
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636282/000163628224000105/syre-20241118.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636282/000163628224000105/

## Items reported

- Item 4.02: Non-reliance on financial statements
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636282/000163628224000105/syre-20241118.htm

Filed Nov 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001636282-24-000105. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.